Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
*MAILING ADDRESS
Clonshaugh Business & Technology Park
*CITY
DUBLIN 17
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Ireland
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
D17E400
PHONE
714-246-4788
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
private company limited by shares (prc)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
035
*IDENTIFICATION
Providing consumer product information regarding medical products to patients and healthcare professionals.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Providing medical information, namely, information regarding medical conditions and treatments to patients and healthcare professionals;
medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment; providing medical information regarding medical products to patients and
healthcare professionals.
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
MATTHEW O. BRADY
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
AbbVie
INTERNAL ADDRESS
AND-250C
STREET
2525 DUPONT DRIVE
CITY
IRVINE
STATE
California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
92612-1531
PHONE
714-246-4788
FAX
(714) 246-3981
EMAIL ADDRESS
mbrady@abbvie.com
OTHER APPOINTED ATTORNEY
Janie L. Thompson
CORRESPONDENCE INFORMATION
NAME
MATTHEW O. BRADY
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
mbrady@abbvie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
alexander.kent@abbvie.com; trademarks@abbvie.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
700
*TOTAL FEES PAID
700
SIGNATURE INFORMATION
SIGNATURE
/mob/
SIGNATORY'S NAME
Matthew O. Brady
SIGNATORY'S POSITION
Attorney of Record-Illinois Bar member
SIGNATORY'S PHONE NUMBER
714-246-4788
DATE SIGNED
03/30/2023
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97866142
Filing Date:03/30/2023
To the Commissioner for Trademarks:
MARK: FOR A LIFT IN RELIEF (Standard Characters, see mark)
The literal element of the mark consists of FOR A LIFT IN RELIEF. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, a private company limited by shares (prc) legally organized under the laws of Ireland, having an address of
Clonshaugh Business & Technology Park
DUBLIN 17 D17E400
Ireland
714-246-4788(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 035: Providing consumer product information regarding medical products to patients and healthcare professionals.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Providing medical information, namely, information regarding medical conditions and treatments to patients and healthcare professionals; medical consultation, namely,
providing advice to healthcare professionals regarding medical conditions and treatment; providing medical information regarding medical products to patients and healthcare professionals.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: MATTHEW O. BRADY. Other appointed attorneys are Janie L. Thompson. MATTHEW O. BRADY of AbbVie, is a member of the XX bar, admitted to the bar
in XXXX, bar membership no. XXX, and the attorney(s) is located at
AND-250C
2525 DUPONT DRIVE
IRVINE, California 92612-1531
United States
714-246-4788(phone)
(714) 246-3981(fax)
mbrady@abbvie.com
MATTHEW O. BRADY submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /mob/ Date: 03/30/2023
Signatory's Name: Matthew O. Brady
Signatory's Position: Attorney of Record-Illinois Bar member
Signatory's Phone Number: 714-246-4788
Signature method: Sent to third party for signature
Payment Sale Number: 97866142
Payment Accounting Date: 03/30/2023
Serial Number: 97866142
Internet Transmission Date: Thu Mar 30 21:17:03 ET 2023
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202303302117043
42849-97866142-8607d7c90c39f8d5ee918adbd
40d5f4f478f3f1329b69698a4ee91399b480792c
c6-DA-17035503-20230330194255624037